Cape Fear BioCapital is a seed‑stage venture capital firm that invests in early‑stage therapeutics and biotech companies operating in North Carolina. The firm focuses on seeding new companies, funding platform and single‑asset drug opportunities with compelling science, and accelerating projects toward IND filing within three years. Based in Durham, NC, it leverages local university talent and a network of follow‑on investors to support the growth of the state’s biotech ecosystem.
No recent news for this company.